Although thalidomide, a drug first sold for morning sickness, was released in 1957, the heartbreak from its damage continues and lessons have not yet been learned—including the need for better research and corporate ethics, the need to care for those hurt by an “advance,” and the importance of strong and ethical oversight from government regulators like Frances Kelsey, the FDA reviewer who prevented the birth defects caused by thalidomide from occurring in the United States by blocking its approval. Read more